Evidence map›Paper›PMID 39586768›Full record

ArticleRevista medica del Instituto Mexicano del Seguro Social2024

[Pre-analytical quality assessment in the microbiology laboratory].

Meztli Monserrat Carbajal-Vázquez, María Guadalupe Carrillo-Montes, Roxana Blanca Rivera-Leaños, Verónica Alicia Farias-Basurto, César Bárcena-Molina

Abstract readEnglish Abstract
In one paragraph

Article in Revista medica del Instituto Mexicano del Seguro Social, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Meztli Monserrat Carbajal-VázquezInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Cardiología, Laboratorio. Ciudad de México, México.ORCID 0009-0009-9884-3762
María Guadalupe Carrillo-MontesInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Unidad de Educación e Investigación, Coordinación de Investigación en Salud, División de Desarrollo de la Investigación en Salud. Ciudad de México, México.ORCID 0000-0001-8812-3555
Roxana Blanca Rivera-LeañosInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Cardiología, Laboratorio. Ciudad de México, México.ORCID 0009-0009-1366-3675
Verónica Alicia Farias-BasurtoInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Cardiología, Laboratorio. Ciudad de México, México.ORCID 0009-0006-4669-7271
César Bárcena-MolinaInstituto de Seguridad Social para los Trabajadores del Estado, Hospital Fernando Quiroz Gutiérrez, Servicio de Cardiología. Ciudad de México, México.ORCID 0009-0006-7000-0315

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Errors in the pre-analytical phase of the microbiology laboratory reduce patient safety and generate additional expenses. In Mexico we do not have systems for evaluation and monitoring of the pre-analytical phase; quality indicators are proposed for continuous improvement. Objective: Identify the main reasons for rejection of respiratory samples in the microbiology laboratory and evaluate the usefulness of preanalytical quality indicators. Material and methods: Cross-sectional study. Review of microbiology laboratory applications from August 2022 to July 2023, calculated the frequency of rejection and identification of the main reasons for it, it was analyzed using quality indicators based on the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Results: Of 3530 processing requests, 582 were for respiratory samples (16.48%), 44 samples rejected due to pre-analytical errors (7.56%), the main causes identified: Transcription error 22.7%, identification error 20.4%, Samples that do not comply Murray-Washington criteria 25.0%, Errors in obtaining/collecting samples 20.4%, Samples with defects in conservation 4.5%, Unidentified samples: 6.8. Conclusions: The main causes of rejection were identified; upon analysis with the preanalytical quality indicators, they were found at desirable levels and in reference ranges; only 4 were useful for long-term implementation.

Indexed as

Quality Indicators, Health CareCross-Sectional StudiesHumansLaboratories, ClinicalMexicoMicrobiological TechniquesPre-Analytical PhaseMicrobiologyPre-Analytical PhaseQuality ControlResearch

Identifiers

PMID39586768
PMCPMC12564796

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.